Categories: sweden

26 March 2025 08:00

Affera™ Mapping and Ablation System Now in Use in Sweden, More Nordic Countries to Follow Soon

The Affera™ Mapping and Ablation System is now in clinical use in Sweden, marking a major step forward in Nordic cardiac care. This advanced system provides real-time feedback to map and treat atrial arrhythmias efficiently and safely. With CE Mark approval and strong clinical results, Medtronic is bringing this groundbreaking technology to more Nordic countries soon.

6 February 2025 06:30

Sahlgrenska Universitetssjukhuset och Medtronic samarbetar för framtidens vård

Strategiskt partnerskap: Medtronic och Sahlgrenska Universitetssjukhuset går in i ett strategiskt partnerskap kring utveckling av framtidens vård. Syftet med partnerskapet är att främja initiativ inom utveckling, innovation och transformation.

4 November 2024 09:00

Medtronic receives CE Mark for Evolut™ FX+ TAVI system for treatment of symptomatic severe aortic stenosis

Newest-generation Evolut TAVI system builds on its market leading valve performance and durability with enhanced coronary access